Cited by 73Sexual Differentiation and DisordersAdrenal Hormones and DisordersHormonal Regulation and Hypertension

A Diagnosis Not to Be Missed: Nonclassic Steroid 11β-Hydroxylase Deficiency Presenting With Premature Adrenarche and Hirsutism

Reisch, Nicole, Högler, Wolfgang, Parajes, Silvia, Rose, Ian T., Dhir, Vivek, Götzinger, Joachim, Arlt, Wiebke, Krone, Nils·2013·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Steroid 11β-hydroxylase (CYP11B1) deficiency (11OHD) is the second most common form of congenital adrenal hyperplasia. Milder nonclassic forms are rare and at risk to be missed. OBJECTIVE: The objective of the study was to demonstrate the challenges in diagnosing nonclassic 11OHD. PATIENTS AND METHODS: Patient 1, a 10-year-old boy, presented with high-normal blood pressure and previously unexplained exaggerated adrenarche from age 4 years. Previous tests at the age of 8 years showed normal 17-hydroxyprogesterone concentrations with increased androgens. Patient 2, a 14-year-old female, presented with facial hirsutism, primary amenorrhea, and high-normal blood pressure. Novel CYP11B1 mutations were functionally analyzed in transiently transfected COS7 cells measuring the conversion of 11-deoxycortisol to cortisol by liquid chromatography-tandem mass spectrometry. RESULTS: Biochemical findings including urinary steroid metabolite analysis by gas chromatography-mass spectrometry were suggestive of 11OHD in all patients. CYP11B1 mutation analysis revealed compound heterozygosity in patient 1 (g.235T>A, p.F79I/g.2608C>T, p.R138C) and a homozygous mutation in patient 2 and two siblings (g.2623C>T, p.R143W). Functional in vitro analysis demonstrated partially impaired CYP11B1 activity compared with wild-type (p.F79I: 8.8% ± 0.8% (SEM); p.R138C: 9.8% ± 0.8%; p.R143W: 10.6% ± 1.2%). CONCLUSION: In addition to nonclassic 21-hydroxylase deficiency and steroid-secreting tumors, nonclassic 11OHD should be considered as an important differential diagnosis in patients with unexplained hyperandrogenism without 46,XX disorder of sex development. Nonclassic 11OHD is likely to be missed when relying on measuring standard steroid hormone panels. This diagnosis needs to be established early in life to avoid long-term health problems such as short stature, hyperandrogenism-related metabolic complications, potentially severe arterial hypertension, and cardiovascular consequences.

Integrity signals

Registry

Crossref · 10.1210/jc.2013-1306

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The diagnosis of POR can be best made with a urinary steroid profile, revealing characteristic precursor accumulation that can be captured by steroid ratios, while serum steroid analysis often yields confusing results due to the overlapping effects of combined 17OH and 21OH deficiency.

    “The diagnosis of POR can be best made with a urinary steroid profile, revealing characteristic precursor accumulation that can be captured by steroid ratios 32 while serum steroid analysis often yields confusing results due to the overlapping effects of combined 17OH and 21OH deficiency.”

    From Congenital adrenal hyperplasia (2017) · cites this paper as [32]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Reisch, N., Högler, W., Parajes, S., Rose, I. T., Dhir, V., Götzinger, J., Arlt, W., & Krone, N.
Affiliations
  • LMU Klinikum (DE)
  • Birmingham Children's Hospital (GB)
  • University of Birmingham (GB)
  • Christian-Albrechts-Universität zu Kiel (DE)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-10
Volume
98
Issue
10
Pages
E1620-E1625
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2027244067
Cited by
73
References
25
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 10 · 2020: 2 · 2019: 2 · 2018: 10 · 2017: 4 · 2016: 8 · 2015: 7 · 2014: 5
FWCI
2.98
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
Wellcome Trust (GR079865MA)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
CYP11B1, congenital adrenal hyperplasia, premature adrenarche, hirsutism, hyperandrogenism, compound heterozygosity, differential diagnosis, primary amenorrhea, short stature, 17-hydroxyprogesterone
MeSH terms
Adolescent, Adrenal Hyperplasia, Congenital, Child, Female, Hirsutism, Humans, Male, Steroid 11-beta-Hydroxylase, Adrenarche

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review